Celmatix

New Data on Fertility in the United States

November 06, 2017
New data on declining fertility in the United States points to a need for new efforts to better understand improving fertility outcomes in women who wait to have their children.
Read More

Speedy Recruitment for Fertility Study

May 26, 2017
With breathtaking speed, 23andMe and Celmatix have finished recruiting and enrolling participants in a groundbreaking study on fertility. Launched in February, the study aimed to enroll 4,500 women. It can...
Read More

Fertility Study Launches

February 22, 2017
A new Fertility Research Community launched by the next-generation women’s health company Celmatix, and 23andMe, will use genetic and other data to uncover more on what impacts a woman’s ability to conceive.
Read More

Collaboration to Create Better Treatments for Infertility

February 10, 2016
As part of a collaboration with 23andMe, the personalized medicine company Celmatix is looking to dramatically improve the diagnosis and treatment of infertility. Infertility affects a large portion of the...
Read More